COVID-19 infection in primary central nervous system lymphoma treatment: Who is most at risk?

Br J Haematol. 2022 Nov;199(4):480-481. doi: 10.1111/bjh.18416. Epub 2022 Aug 26.
No abstract available

MeSH terms

  • COVID-19*
  • Central Nervous System / pathology
  • Central Nervous System Neoplasms* / pathology
  • Central Nervous System Neoplasms* / therapy
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / pathology